2018 Annual Meeting

Recognizing that there is an ever-increasing amount of new information that is useful to the general practice of pathology, a series of Special Conferences utilizing case material is made available at the annual meeting of the Academy. The objective for these conferences is to show how newly acquired information, recent technical advances and updated concepts are used in the pathological diagnosis of complex cases. Specialty Conferences, in most instances, have a virtual slide for each case, in addition to, still digital images and case histories available on the website at least a month prior to the Annual Meeting. This enables registrants to study the slides before coming to the meeting. A complete syllabus with diagnoses will be placed on the website the morning after the conference, and will remain online after the meeting has ended.

Sunday Monday Tuesday Wednesday Thursday

Sunday, March 18, 2018 - 7:30 pm – 9:30 pm

Bone and Soft Tissue Pathology

Recent Molecular Insights into the Pathogenesis of Bone and Soft Tissue Tumors: Clinical Implications and Diagnostic Applications

Moderator

Jason L. Hornick, MD, PhD, Brigham and Women’s Hospital, Boston, MA

Faculty

Brian Rubin, MD, PhD, Cleveland Clinic, Cleveland, OH
Judith Bovee, MD, PhD, Leiden University Medical Center, Leiden, Netherlands
Cheng-Han Lee, MD, PhD, British Columbia Cancer Agency, Vancouver, BC, Canada
Jean-Michel Coindre, MD, Institute Bergonie, Bordeaux, France

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe recent molecular insights in the field of bone and soft tissue pathology that have led to the development of new diagnostic approaches or tools
  • Identify the clinical significance of such insights in order to guide patient management
  • Recognize the appropriate use of new diagnostic approaches in clinical practice for the evaluation of bone and soft tissue lesions

 

Hematopathology

New WHO, New Challenges

Moderators

James R. Cook, MD, PhD, Cleveland Clinic, Cleveland, OH
Tracy George, MD, University of New Mexico, Albuquerque, NM

Faculty

Kathy Calvo, MD, National Institutes of Health, Bethesda, MD
Kaaren Reichard, MD, Mayo Clinic, Rochester, MN
Mohamed E. Salama, MD, The University of Utah, Salt Lake City, UT
Sarah Ondrejka, DO, Cleveland Clinic, Cleveland, OH

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the key morphologic features associated with specific hematopoietic disorders
  • Identify appropriate ancillary studies that aid in establishing a diagnosis by current WHO criteria
  • Measure their skills in diagnostic hematopathology against the panel experts

 

Pathologist-in-Training Pathology

Succeeding in Pathology Practice (Beyond Residency and Fellowship)

Moderator

Barbara Ducatman, MD, Oakland University William Beaumont School of Medicine, Royal Oak, MI

Faculty

Kurt Bernacki, MD, Oakland University William Beaumont School of Medicine, Royal Oak, MI
Vaishali Pansare, MD, Oakland University William Beaumont School of Medicine, Royal Oak, MI
Barbara Ducatman, MD, Oakland University William Beaumont School of Medicine, Royal Oak, MI

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the similarities and differences between academic and community practice
  • Describe the knowledge and skills that lead to successful practice in either system
  • Describe how to best prepare for a leadership role

 

Infectious Disease Pathology

Artifacts!

Moderator

Atis Muehlenbachs, MD, Centers for Disease Control and Prevention, Atlanta, GA

Faculty

Bobbi Pritt, MD, Mayo Clinic, Rochester, MN
Martin Hale, MD, University of the Witwatersrand, Johannesburg, South Africa
Gillian Hale, MD, MPH, Centers for Disease Control and Prevention, Atlanta, GA
Audrey Schuetz, MD, Mayo Clinic, Rochester, MN

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe common and unusual artifacts that can mimic infectious organisms in pathology specimens
  • Identify pitfalls in immunohistochemical and molecular testing that can lead to misdiagnoses of infectious diseases
  • Measure participant knowledge of the impact of artifacts on the practice of infectious disease pathology

 

Ophthalmic Pathology

The Role of Pathologic Examination in Neuro-Ophthalmology: Selected Cases

Moderator

Fausto J. Rodriguez, MD, Johns Hopkins University, Baltimore, MD

Faculty

Thomas Cummings, MD, Duke University Medical Center, Durham, NC
Charles Specht, MD, Pennsylvania State Hershey Medical Center, Hershey, PA
Marie Rivera-Zengotita, MD, University of Florida, Gainesville, FL
Melike Pekmezci, MD, University of California, San Francisco, CA
Marta Couce, MD, PhD, University Hospital, Cleveland, OH

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Describe the role of biopsy in the evaluation of pathologic lesions involving the retina and optic nerve
  • Identify the spectrum of neoplasms and pseudoneoplastic lesions that may come to attention in neuro-ophthalmology
  • Identify appropriate ancillary tests for the workup of neuro-ophthalmic lesions

 

Pediatric Pathology

Selected Topics in Pediatric Head and Neck Pathology

Moderators

Kyle Kurek, MD, Alberta Children’s Hospital and University of Calgary, Calgary, AB, Canada
Megan K. Dishop, MD, Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN

Faculty

John Ozolek, MD, Children’s Hospital of Pittsburgh, Pittsburgh, PA
Bo-Yee Ngan, MD, Hospital for Sick Children, University of Toronto, Ontario, Canada
Sook-Bin Woo, DMD, Brigham and Women’s Hospital, Boston, MA
Robyn C. Reed, MD, PhD, Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the differential diagnosis of neoplastic and non-neoplastic lesions involving the thyroid, salivary gland, mandible, and Aden tonsillar lymphoid tissue in children
  • Identify key histopathologic features for thyroid, salivary gland, mandibular, and tonsillar lesions in children
  • Select ancillary studies and molecular testing that aids in the diagnosis of pediatric head and neck lesions

 

 

Back to Top    Sunday Monday Tuesday Wednesday Thursday

Monday, March 19, 2018 - 7:30 pm – 9:30 pm

Cardiovascular Pathology

Cancer and the Cardiovascular System: Primaries and Therapeutic Complications

Moderators

Henry Tazelaar, MD, Mayo Clinic, Scottsdale, AZ
Robert Padera, MD, PhD, Brigham and Women’s Hospital, Boston, MA

Faculty

Dylan Miller, MD, Intermountain Central Lab, Salt Lake City, UT
Mathieu Castonguay, MD, Dalhousie University, Halifax, Nova Scotia, Canada
Gregory Fishbein, MD, University of California, Los Angeles, CA
Peter Lin, MD, Mayo Clinic, Rochester, MN
Margot Davis, MD, Vancouver General Hospital, Vancouver, BC, Canada

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the pathology and differential diagnoses of primary cardiac malignancies
  • Identify the cardiovascular pathologies associated with traditional and novel therapies for non-cardiac malignancies

 

Neuropathology

What’s New in Surgical Neuropathology?

Moderator

Anthony Yachnis, MD, University of Florida, Gainesville, FL

Faculty

Cynthia Hawkins, MD, PhD, Hospital for Sick Children, University of Toronto, Ontario, Canada
Anat Stemmer-Rachamimov, MD, Massachusetts General Hospital, Boston, MA
Christopher Dunham, MD, University of British Columbia, Vancouver, BC, Canada
Craig M. Horbinski, MD, Northwestern University, Chicago, IL
Fausto Rodriguez, MD, Johns Hopkins University, Baltimore, MD

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the application of molecular diagnosis to practical problems in surgical neuropathology
  • Identify contemporary approaches to integrated molecular diagnosis and conventional tumor grading
  • Measure possible effects of integrated neuropathological diagnosis on patient management

 

Surgical Pathology

My Most Memorable Cases (aka a great story!)

Moderator

Kumarasen Cooper, MBChB, DPhil, University of Pennsylvania Hospital, Philadelphia, PA

Faculty

Saul Suster, MD, The Medical College of Wisconsin, Milwaukee, WI
Paul Wakely, MD, The Ohio State University Wexner Medical Center, Columbus, OH
Virginia LiVolsi, MD, University of Pennsylvania, Philadelphia, PA
Thomas Krausz, MD, The University of Chicago Hospital, Chicago, IL
Christopher Fletcher, MD, Brigham and Women’s Hospital, Boston, MA

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe and appreciate the nuances of general surgical pathology
  • Identify and recognize interesting tumors and lesions from different organ sites

 

 

Back to Top    Sunday Monday Tuesday Wednesday Thursday

Tuesday, March 20, 2018 - 7:30 pm – 9:30 pm

Breast Pathology

A Case I Will Never Forget

Moderator

Melinda Sanders, MD, Vanderbilt University, Nashville, TN

Faculty

Anne Vincent-Salomon, MD, PhD, Institute Curie, Paris, France
Gabrielle Baker, MD, Beth Israel Deaconess Medical Center, Boston, MA
Gelareh Farshid, MBBS, MD, South Australian Pathology, Adelaide, Australia
Edi Brogi, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY
Yunn-Yi Chen, MD, PhD, University of California, San Francisco, CA

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe approaches to diagnosis of complex/unusual breast lesions
  • Identify histologic features and molecular tools to facilitate the correct diagnosis
  • Measure satisfaction of clinicians with increased diagnostic accuracy and clarity of reporting complex/unusual breast lesions

 

Dermatopathology

Pitfalls in Dermatopathology: When Things are NOT What They SEEM to Be

Moderator

Aleodor (Doru) Andea, University of Michigan, Ann Arbor, MI

Faculty

Richard A. Scolyer, MBBS, MD, Royal Prince Alfred Hospital, Camperdown, Australia
May P. Chan, MD, University of Michigan, Ann Arbor, MI
Patrick O. Emanuel, MB ChB, FRCPA, The University of Auckland, New Zealand
Rosalynn M. Nazarian, MD, Massachusetts General Hospital, Boston, MA
Deborah L. Cook, MD, The University of Vermont Medical Center, Burlington, VT

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe a variety of dermatopathology cases that are prone to be misdiagnosed
  • Identify histological features that are useful in preventing pitfalls in diagnosis
  • Determine appropriate ancillary studies that help arrive at the correct diagnosis

 

Gastrointestinal Pathology

Tales from the Crypt: Creepy Cancers and Colitis

Moderator

Rhonda Yantiss, MD, Weill Cornell Medical College, New York, NY

Faculty

Larry Burgart, MD, Abbott Northwestern Hospital, Minneapolis, MN
Tomas Slavik, MD, Ampath Histology and Cytology Lab, Pretoria, South Africa
Jinru Shia, MD, Memorial Sloan Kettering, New York, NY
Christophe Rosty, MD, PhD, The University of Queensland, Brisbane, Australia
Mary Bronner, MD, University of Utah, Salt Lake City, UT

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe criteria that distinguish between malignant epithelioid cell tumors of the GI tract
  • Identify Features that distinguish drug-induced and autoimmune forms of colitis from potential mimics
  • Interpret immunohistochemical stains used to evaluate colorectal cancers for mismatch repair deficiency

 

Renal Pathology

Interesting Cases with Important Teaching Points

Moderators

Vanesa Bijol, MD, Northwell Health - Hofstra School of Medicine, New Hyde Park, NY
Tibor Nadasdy, MD, The Ohio State University, Columbus, OH

Faculty

Mark Haas, MD, PhD, Cedars-Sinai Medical Center, West Hollywood, CA
Randolph Hennigar, MD, PhD, Arkana Laboratories, Little Rock, AR
Leal Herlitz, MD, Cleveland Clinic, Cleveland, OH
Loren Herrera-Hernandez, MD, Mayo Clinic, Rochester, MN
Anjali Satoskar, MD, The Ohio State University, Columbus, OH

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the known mechanisms of kidney injury in discussed entities
  • Identify common histopathologic features in discussed entities
  • Measure important variables critical for diagnostic or management purposes, if applicable, in different discussed entities

 

 

Back to Top    Sunday Monday Tuesday Wednesday Thursday

Wednesday, March 21, 2018 - 7:30 pm – 9:30 pm

Cytopathology

Fine-Needle Aspiration of Cystic Lesions: Challenges Encountered and Lessons Learned

Moderator

Zubair Baloch, University of Pennsylvania, Philadelphia, PA

Faculty

Willian C. Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA
Michelle Reid, MD, Emory University, Atlanta, GA
Scott Boerner, MD, FRCPE, University Health Network, Toronto, ON, Canada
Liron Pantanowitz, MD, University of Pittsburgh, Pittsburgh, PA

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe key cytologic features to differentiate between primary and metastatic cystic lesions
  • Identify diagnostic challenges and pitfalls with limited cellularity specimens obtained from cystic lesions
  • Measure the value of special techniques in the diagnosis of cystic lesions of head and neck and pancreas

 

Genitourinary Pathology

Diagnostic Pitfalls in Genitourinary Pathology

Moderator

Michelle S. Hirsch, MD, PhD, Brigham and Women’s Hospital, Boston, MA

Faculty

Rohit Mehra, MD, University of Michigan, Ann Arbor, MI
Fiona Maclean, MBBS, FRCPA, Douglass Hanly Moir Pathology, Macquaire Park, Australia
Brian Robinson, MD, Weill Cornell Medicine, New York, NY
Chia-Sui Kao, MD, Stanford Health Care, Stanford, CA

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the morphologic differences between benign and malignant lesions in the GU tract
  • Identify the usefulness and limitations of biomarker studies in the GU tract
  • Measure their ability to distinguish secondary tumors from primary lesions in the GU tract

 

Gynecologic Pathology

Endometrial Carcinoma: Recent Developments that Impact on Practice

Moderator

C. Blake Gilks, Vancouver General Hospital, Vancouver, BC, Canada

Faculty

Esther Oliva, MD, Massachusetts General Hospital, Boston, MA
Tjalling Bosse, MD, PhD, Leiden University Medical Center, Leiden, Netherlands
Lien Hoang, MD, Vancouver General Hospital, Vancouver, Canada
Rob Soslow, MD, Memorial Sloan Kettering Cancer Center, New York, NY

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe important recent developments in endometrial cancer pathology
  • Identify recently described endometrial carcinoma variants that fall outside conventional Type I or Type II categories
  • Measure lymph vascular invasion in a reproducible and clinically relevant way

 

Head, Neck, and Endocrine Pathology

Challenging Cases and Concepts in Head and Neck and Endocrine Pathology

Moderator

Raja Seethala, MD, University of Pennsylvania, Philadelphia, PA

Faculty

Roderick H.W. Simpson, BSC, MB ChB, MMed, University of Calgary, Calgary, Canada
Ilan Weinreb, MD, FRCPC, UHN Laboratory Medicine Program, Toronto, Canada
Kathleen Montone, MD, University of Pennsylvania, Philadelphia, PA
Elizabeth Bilodeau, DMD, MD, University of Pittsburg, Pittsburgh, PA

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe unusual salivary type, odontogenic and midfacial destructive lesions
  • Identify distinctive clinicopathologic criteria to delineate granulomatous and non-granulomatous sinonasal inflammatory lesions, and jaw/craniofacial odontogenic neoplasms
  • Measure immunoexpression profiles of discriminatory value for intraductal salivary tumors

 

Pulmonary Pathology

Best Example of … I have Ever Seen!

Moderator

Alain Borczuk, MD, Cornell University Medical Center, New York, NY

Faculty

Brandon T. Larsen, MD, PhD, Mayo Clinic Arizona, Scottsdale, AZ
Andrew Churg, MD, PhD, Vancouver General Hospital, Vancouver, BC, Canada
Roberto Barrios, MD, The Methodist Hospital, Houston, TX
Prudence Russell, FRCPA, St. Vincent’s University Hospital, Fitzroy, Vic, Australia
Alain C. Borczuk, MD, Cornell University Medical Center, New York, NY

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe classical pathologic features of diagnostically important entities in pulmonary disease
  • Identify pitfalls in the current classification and diagnosis of these unusual entities
  • Measure efficacy of a criteria based approach to rendering these diagnoses

 

 

Back to Top    Sunday Monday Tuesday Wednesday Thursday

Thursday, March 22, 2018 - 7:30 pm – 9:30 pm

Liver Pathology

Secrets from the Consult Files: Puzzling Cases Solved Piece by Piece

Moderator

Michael Torbenson, MD, Mayo Clinic, Rochester, MN

Faculty

Maria Westerhoff, MD, University of Michigan, Ann Arbor, MI
Tom Smyrk, MD, Mayo Clinic Rochester, MN
ILKe Nalbantoglu, MD, Yale University, New Haven, CT
Raul Gonzalez, MD, University of Rochester Medical Center, Rochester, NY

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  • Describe the clinical significance of histological findings
  • Identify the key histological features of liver disease patterns
  • Measure the role of immunostains and other ancillary testing in liver pathology

 

 

Back to Top    Sunday Monday Tuesday Wednesday Thursday

 

Continuing Medical Education and Maintenance of Certification

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 2 SAM credit hours.

Register Now!

Meetings

view more